Company profile
Chalice Brands Ltd
OTC: CHALF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ORReports USD
#507 of 1,418 Healthcare companies by revenue72nd-percentile growth
EA Score
——FH —DQ —GM —SS 41
v0.1 · 5/100 weight · pillars only
↑ operating margin, return on assets · ↓ market scale, balance-sheet leverage
Methodology →Revenue TTM
$26.0M
Rev growth YoY (TTM)
+36.2%
Net income (FY)
$0
Employees
98
as of 2026-08-30
Market cap
$6.7k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$29.0M$29.0M2021
Net income$0$02021
Operating income$12.5M$12.5M2021
Total assets$28.0M$28.0M2020
Liabilities$22.5M$22.5M2020
Equity$5.5M$5.5M2020
Revenue trend
FY2014 – FY2021 · USD
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Chalice Brands Ltd’s revenue?
Chalice Brands Ltd booked $29.0M in FY2021 revenue, growing 33% year over year — faster than most Healthcare companies we track, at a 0.0% net margin.
Key facts
CEOJeffrey Yapp
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, OR
ExchangeOTC: CHALF
Employees98
IPO date2016-02-18
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.